1. Development of a prediction model to estimate the 5-year risk of cardiovascular events and all-cause mortality in haemodialysis patients: a retrospective study.
- Author
-
Aihong Zhang, Lemuge Qi, Yanping Zhang, Zhuo Ren, Chen Zhao, Qian Wang, Kaiming Ren, Jiuxu Bai, and Ning Cao
- Subjects
HEMODIALYSIS patients ,MORTALITY ,PREDICTION models ,CARDIOVASCULAR diseases risk factors ,DISEASE risk factors ,LOGISTIC regression analysis ,MULTIVARIABLE testing - Abstract
Background. Cardiovascular disease (CVD) is a major cause of mortality in patients on haemodialysis. The development of a prediction model for CVD risk is necessary to help make clinical decisions for haemodialysis patients. This retrospective study aimed to develop a prediction model for the 5-year risk of CV events and all-cause mortality in haemodialysis patients in China. Methods. We retrospectively enrolled 398 haemodialysis patients who underwent dialysis at the dialysis facility of the General Hospital of Northern Theater Command in June 2016 and were followed up for 5 years. The composite outcome was defined as CV events and/or all-cause death. Multivariable logistic regression with backwards stepwise selection was used to develop our new prediction model. Results. Seven predictors were included in the final model: age, male sex, diabetes, his- tory of CV events, no arteriovenous fistula at dialysis initiation, a monocyte/lymphocyte ratio greater than 0.43 and a serum uric acid level less than 436 mmol/L. Discrimination and calibration were satisfactory, with a C-statistic above 0.80. The predictors lay nearly on the 45-degree line for agreement with the outcome in the calibration plot. A simple clinical score was constructed to provide the probability of 5-year CV events or all-cause mortality. Bootstrapping validation showed that the new model also has similar discrimination and calibration. Compared with the Framingham risk score (FRS) and a similar model, our model showed better performance. Conclusion. This prognostic model can be used to predict the long-term risk of CV events and all-cause mortality in haemodialysis patients. An MLR greater than 0.43 is an important prognostic factor. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF